All News

A biologics license application has been submitted to the FDA for the accelerated approval of tisotumab vedotin for use in patients with recurrent or metastatic cervical cancer that has progressed on or following chemotherapy.

Investigators also recommended a method of knotting and tucking in the sides of a medical mask, in order to minimize the leakage of air around the edges.

On-demand, continuing education video series provides exclusive access to the latest information and updates on the pandemic and vaccine.

Libtayo is the first treatment to show a clinical benefit in patients with advanced basal cell carcinoma after hedgehog pathway inhibitor therapy in a pivotal trial.

Some OTC nonsteroidal anti-inflammatory drugs or combination analgesics can be used to treat migraine in children.

Patients with multiple sclerosis who rely on family members as caregivers may be at particular risk for mistreatment, as those caregivers struggle to balance work, childcare, and health concerns of their own.

Medication misuse can cause many health issues, including death, but knowledge and proper treatment can reduce these tragic occurrences.

Experts say the clinical presentation of herpes zoster in pregnant women should be carefully monitored and reported for further assessment, especially if it is associated with other signs of COVID-19.

Research shows that closed-loop systems can increase time in range and reduce both hyperglycemia and hypoglycemia in youth and young adults.

There are 3 more COVID-19 vaccines that are expected to become available in the United States in the coming months from AstraZeneca, Johnson & Johnson, and Novavax, with specific implications for each one.

First approved by the FDA in 1989 for 2 rare eye muscle disorders, onabotulinumtoxinA (Botox; Allergan) was the world’s first approved botulinum toxin type A treatment.

The product portfolio includes lamotrigine (ET-105), zonisamide (ET-104), and topiramate (ET-101). These medications are currently under review with the FDA.

A clinical trial of patients with COVID-19 at high risk for disease progression showed that a single intravenous infusion of bamlanivimab and etesevimab together significantly reduce COVID-19-related hospitalization and death.

Women whose tumors responded to estrogen treatment were found to benefit from hormone therapy, whereas those whose tumors did not respond experienced worsening disease.

Migraine attacks are the leading cause of disability in individuals younger than 50 years and predominantly affect women.

Moreover, 9 in 10 adults say that they hope the country moves toward unity, according to Stress in America: January 2021 Stress Snapshot, conducted by The Harris Poll on behalf of the American Psychological Association (APA).

Four months after training, military personnel reported less stress and depressive symptoms as well as more satisfaction and resilience in their lives.

Pharmacists must develop professional behavior and a common professional identity that goes beyond their personal values and self-interests.

Across all of the nations studied, investigators found that the United States accounted for 58% of all prescription drug sales but just 24% of the volume.

The BTD designations for asciminib were based on the phase 3, multicenter, open-label, randomized ASCEMBL trial and a phase I trial that included patients with Ph+ CML, some of them harboring the T315I mutation.

The investigators said the undertreatment of coronary artery disease in women largely stems from a failure to recognize key differences in cardiovascular risk factors and symptoms in women.

Investigators are working to create a second generation of the vaccine, adapted to target variants with mutations similar to those found in South Africa.

Of 192 study participants who received Breyanzi, 73% achieved a response, including 54% who had minimal or no detectable lymphoma remaining following treatment and 19% who achieved a partial response.

In order to eradicate HIV, the researchers said increasing health coverage will be essential. Without that, HIV will continue to spread, and individuals will be unaware of their status.

The national advocacy organization for women pharmacists strengthens MJH’s position in the pharmacy industry.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week:

The report, developed by Thomas McAndrew, a computational scientist and faculty member at Lehigh University's College of Health, and colleagues, uses data from experts and trained forecasters, combining their predictions into a single consensus forecast.

The program educates patients on how to use the FreeStyle Libre 2 system as well as ways to positively impact their glucose levels through diet and fitness.